| 000 | 03717nam a22003615i 4500 | ||
|---|---|---|---|
| 001 | 233803 | ||
| 003 | ES-VaUE | ||
| 005 | 20221220020522.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 100301s2000 xxu| s |||| 0|eng d | ||
| 020 | _a9781592590759 | ||
| 024 | 7 |
_a10.1385/1592590756 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC |
||
| 245 | 1 | 0 |
_aDrug Targeting _bStrategies, Principles, and Applications _cedited by G. E. Francis. |
| 250 | _a1st edition 2000 | ||
| 264 | 1 |
_aTotowa, NJ _bHumana Press _c2000 |
|
| 300 |
_a1 recurso en línea (X, 318 páginas) _b |
||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_aarchivo de texto _bPDF |
||
| 490 | 0 |
_aMethods in Molecular Medicine _x1940-6037 _v25 |
|
| 505 | 0 | _aStrategies -- Chemical Construction of Immunotoxins -- Construction of Ribonuclease-Antibody Conjugates for Selective Cytotoxicity -- Intracellular Targeting Using Bispecific Antibodies -- Antibody Conjugation Methods for Active Targeting of Liposomes -- Folate as a Targeting Device for Proteins Utilizing Folate Receptor-Mediated Endocytosis -- Preparation of Recombinant RNase Single-Chain Antibody Fusion Proteins -- Theoretical Aspects -- Practical Considerations in the Exploitation of Passive Tumor Targeting -- Effect of Dose, Molecular Size, and Binding Affinity on Uptake of Antibodies -- Inhibition of Tumor Blood Flow -- Applications -- 10 Targeting in Myocardial Infarction -- 11 Targeting HIV-Infected Cells -- 12 Making Fusion Toxins to Target Leukemia and Lymphoma -- Antibody-Bearing Liposomes as Chloroquine Vehicles in Treatment of Murine Malaria -- 14 Immunotargeting of Catalase to the Pulmonary Vascular Endothelium -- 15 Targeted Gene Transfer. | |
| 520 | _aIn Drug Targeting: Strategies, Methods, and Protocls, Gillian E. Francis and Cristina Delgado have assembled an outstanding collection of leading-edge protocols for drug targeting studies. In addition to providing detailed step-by-step instructions, the highly experienced authors review the principal current targeting strategies, discuss how to build the constructs, examine theoretical considerations relevant to solid tumors, and describe experimental and clinical applications of targeted drug delivery systems. Also presented are new chemical and biological approaches to the preparation of targeted biopharmaceuticals, including ribonuclease-antibody chimeras, bispecific antibodies, enzyme-antibody conjugates, and folate-bearing conjugates. Applications include the targeting of myocardial infarctions using liposomal systems, the use of monoclonal antibodies to target malaria and HIV-infected cells, the targeting of fusion proteins to leukemias and lymphomas, the use of antioxidant enzyme-antibody conjugates to target the pulmonary endothelium, as well as methods addressing both the active and passive targeting of tumors. Comprehensive and innovative, Drug Targeting: Strategies, Methods, and Protocols documents in practical detail the major new chemical and biological targeting methods now being used to produce today's emerging rich array of novel diagnostic agents and promising biopharmaceuticals. | ||
| 700 | 1 |
_aFrancis, G. E _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9781489941718 |
| 776 | 0 | 8 |
_iPrinted edition: _z9780896035317 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781489941701 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1385/1592590756 _z(usuarios Universidad Europea de Valencia) |
| 942 |
_2lcc _cLE |
||
| 988 | _aSpringer_Protocols_2000 | ||
| 999 |
_c233803 _d233803 |
||